Cargando…

Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report

RATIONALE: Nephrogenic diabetes insipidus (NDI) rarely presents in the initial stage of acute lymphoblastic leukemia (ALL) and relapse due to renal infiltration is also rare. PATIENT CONCERNS: A 19-year-old man presented with weakness, polydipsia, and polyuria for 1 month. DIAGNOSES: NDI was diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dezhi, Liu, Qian, Feng, Zhifang, Zhang, Qi, Feng, Saran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024069/
https://www.ncbi.nlm.nih.gov/pubmed/29901649
http://dx.doi.org/10.1097/MD.0000000000011157
_version_ 1783335988234289152
author Li, Dezhi
Liu, Qian
Feng, Zhifang
Zhang, Qi
Feng, Saran
author_facet Li, Dezhi
Liu, Qian
Feng, Zhifang
Zhang, Qi
Feng, Saran
author_sort Li, Dezhi
collection PubMed
description RATIONALE: Nephrogenic diabetes insipidus (NDI) rarely presents in the initial stage of acute lymphoblastic leukemia (ALL) and relapse due to renal infiltration is also rare. PATIENT CONCERNS: A 19-year-old man presented with weakness, polydipsia, and polyuria for 1 month. DIAGNOSES: NDI was diagnosed with insignificant response to a water deprivation test after stimulation with vasopressin injection. Bone marrow examination combined with immunophenotypic analysis, cerebrospinal cytology, and abdominal ultrasonography confirmed the diagnoses of precursor B cell ALL with renal infiltration. INTERVENTIONS: The patient accepted standardized combination chemotherapy and ultimately had sustained remission, and his polydipsia and polyuria disappeared after 3 days of treatment. The ALL relapsed 1 year later and he received haploidentical stem cell transplantation (haplo-SCT) from his father. OUTCOMES: One year later, he again developed NDI, with bilateral renal enlargement because of extramedullary relapse, leading to subsequent death. LESSONS: This case demonstrates unusual early renal involvement in ALL presenting with initial NDI. Interestingly, the NDI returned with the relapse of renal infiltration 1 year after haplo-SCT. This case suggests that NDI was probably secondary to renal leukemic infiltration.
format Online
Article
Text
id pubmed-6024069
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-60240692018-07-03 Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report Li, Dezhi Liu, Qian Feng, Zhifang Zhang, Qi Feng, Saran Medicine (Baltimore) Research Article RATIONALE: Nephrogenic diabetes insipidus (NDI) rarely presents in the initial stage of acute lymphoblastic leukemia (ALL) and relapse due to renal infiltration is also rare. PATIENT CONCERNS: A 19-year-old man presented with weakness, polydipsia, and polyuria for 1 month. DIAGNOSES: NDI was diagnosed with insignificant response to a water deprivation test after stimulation with vasopressin injection. Bone marrow examination combined with immunophenotypic analysis, cerebrospinal cytology, and abdominal ultrasonography confirmed the diagnoses of precursor B cell ALL with renal infiltration. INTERVENTIONS: The patient accepted standardized combination chemotherapy and ultimately had sustained remission, and his polydipsia and polyuria disappeared after 3 days of treatment. The ALL relapsed 1 year later and he received haploidentical stem cell transplantation (haplo-SCT) from his father. OUTCOMES: One year later, he again developed NDI, with bilateral renal enlargement because of extramedullary relapse, leading to subsequent death. LESSONS: This case demonstrates unusual early renal involvement in ALL presenting with initial NDI. Interestingly, the NDI returned with the relapse of renal infiltration 1 year after haplo-SCT. This case suggests that NDI was probably secondary to renal leukemic infiltration. Wolters Kluwer Health 2018-06-15 /pmc/articles/PMC6024069/ /pubmed/29901649 http://dx.doi.org/10.1097/MD.0000000000011157 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Research Article
Li, Dezhi
Liu, Qian
Feng, Zhifang
Zhang, Qi
Feng, Saran
Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report
title Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report
title_full Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report
title_fullStr Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report
title_full_unstemmed Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report
title_short Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report
title_sort nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: a case report
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024069/
https://www.ncbi.nlm.nih.gov/pubmed/29901649
http://dx.doi.org/10.1097/MD.0000000000011157
work_keys_str_mv AT lidezhi nephrogenicdiabetesinsipidusininitialstageofacutelymphoblasticleukemiaandrelapseafterhaploidenticalhematopoieticstemcelltransplantationacasereport
AT liuqian nephrogenicdiabetesinsipidusininitialstageofacutelymphoblasticleukemiaandrelapseafterhaploidenticalhematopoieticstemcelltransplantationacasereport
AT fengzhifang nephrogenicdiabetesinsipidusininitialstageofacutelymphoblasticleukemiaandrelapseafterhaploidenticalhematopoieticstemcelltransplantationacasereport
AT zhangqi nephrogenicdiabetesinsipidusininitialstageofacutelymphoblasticleukemiaandrelapseafterhaploidenticalhematopoieticstemcelltransplantationacasereport
AT fengsaran nephrogenicdiabetesinsipidusininitialstageofacutelymphoblasticleukemiaandrelapseafterhaploidenticalhematopoieticstemcelltransplantationacasereport